Parisi Gray Wealth Management’s BioNTech BNTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-3,980
Closed -$598K 90
2022
Q4
$598K Buy
3,980
+769
+24% +$118K 0.29% 62
2022
Q3
$433K Sell
3,211
-801
-20% -$122K 0.33% 52
2022
Q2
$598K Sell
4,012
-7
-0.2% -$1.07K 0.31% 61
2022
Q1
$685K Buy
4,019
+76
+2% +$12.8K 0.28% 67
2021
Q4
$1.02M Buy
3,943
+112
+3% +$30.7K 0.38% 53
2021
Q3
$976K Buy
3,831
+168
+5% +$53.4K 0.4% 51
2021
Q2
$820K Buy
+3,663
New +$691K 0.3% 61

Other funds holding BNTX

Parisi Gray Wealth Management's BNTX Position: Q1 2023 in Review

Parisi Gray Wealth Management sold out of BioNTech (BNTX) in Q1 2023, closing a stake of 3,980 shares — an estimated $598K sold.

Parisi Gray Wealth Management first reported a position in BNTX in Q2 2021 and held it in 7 quarters. The position peaked at $1.02M in Q4 2021. 282 funds tracked by Wall St. Rank hold BNTX as of Q1 2023.

  • Parisi Gray Wealth Management reported no remaining BioNTech position as of Q1 2023 after selling out during the quarter.
  • Parisi Gray Wealth Management sold 3,980 BioNTech shares in Q1 2023, an estimated $598K.
  • Parisi Gray Wealth Management first reported a position in BioNTech in Q2 2021 and held it in 7 quarters.
  • Parisi Gray Wealth Management's BioNTech position peaked at $1.02M in Q4 2021.
  • 282 funds tracked by Wall St. Rank held BioNTech as of Q1 2023.

Based on Parisi Gray Wealth Management's 13F filing for Q1 2023, filed 11 Apr 2023.